Werner Bollag

1.5k total citations
25 papers, 1.2k citations indexed

About

Werner Bollag is a scholar working on Molecular Biology, Genetics and Biochemistry. According to data from OpenAlex, Werner Bollag has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Biochemistry. Recurrent topics in Werner Bollag's work include Retinoids in leukemia and cellular processes (18 papers), Estrogen and related hormone effects (7 papers) and Antioxidant Activity and Oxidative Stress (7 papers). Werner Bollag is often cited by papers focused on Retinoids in leukemia and cellular processes (18 papers), Estrogen and related hormone effects (7 papers) and Antioxidant Activity and Oxidative Stress (7 papers). Werner Bollag collaborates with scholars based in Switzerland, United States and Italy. Werner Bollag's co-authors include Yoh Takuwa, H Rasmussen, Noriko Takuwa, Richard Peck, L Isnardi, P Raffo, Salvatore Toma, Giuseppe Dastoli, Lucia Riccardi and Raffaella Palumbo and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and The FASEB Journal.

In The Last Decade

Werner Bollag

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Werner Bollag Switzerland	14	918	263	211	184	157	25	1.2k
Theodore R. Breitman United States	19	879 1.0×	224 0.9×	182 0.9×	193 1.0×	154 1.0×	29	1.1k
Laura Rossi Italy	21	477 0.5×	134 0.5×	264 1.3×	23 0.1×	216 1.4×	39	1.1k
Mattia Frontini United Kingdom	24	1.0k 1.1×	228 0.9×	204 1.0×	61 0.3×	176 1.1×	42	1.5k
Arlette Maret France	18	746 0.8×	178 0.7×	312 1.5×	23 0.1×	138 0.9×	48	1.3k
Barry J. Maurer United States	17	1.0k 1.1×	84 0.3×	97 0.5×	38 0.2×	164 1.0×	40	1.3k
Mariarosaria D’Errico Italy	23	1.3k 1.4×	187 0.7×	104 0.5×	15 0.1×	340 2.2×	40	1.8k
Luowei Li United States	18	852 0.9×	73 0.3×	118 0.6×	12 0.1×	199 1.3×	29	1.2k
Teresa N. Faria United States	23	1.1k 1.2×	330 1.3×	270 1.3×	22 0.1×	294 1.9×	29	2.0k
Claire Racaud‐Sultan France	22	951 1.0×	142 0.5×	166 0.8×	37 0.2×	320 2.0×	40	1.8k
Paola Comi Italy	28	971 1.1×	141 0.5×	148 0.7×	46 0.3×	135 0.9×	72	1.9k

Countries citing papers authored by Werner Bollag

Since Specialization

Citations

This map shows the geographic impact of Werner Bollag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Bollag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Bollag more than expected).

Fields of papers citing papers by Werner Bollag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Bollag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Bollag. The network helps show where Werner Bollag may publish in the future.

Co-authorship network of co-authors of Werner Bollag

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Bollag. A scholar is included among the top collaborators of Werner Bollag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Bollag. Werner Bollag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grenningloh, Roland, Pietro Di Lucia, Michael Klaus, et al.. (2006). Cutting Edge: Inhibition of the Retinoid X Receptor (RXR) Blocks T Helper 2 Differentiation and Prevents Allergic Lung Inflammation. The Journal of Immunology. 176(9). 5161–5166. 29 indexed citations

Nowicka, Dorota, et al.. (1998). Calcitriol enhances antineoplastic and antiangiogenic effects of interleukin-12. Archives of Dermatological Research. 290(12). 696–700. 1 indexed citations

Toma, Salvatore, L Isnardi, P Raffo, et al.. (1998). RARα antagonist RO 41-5253 inhibits proliferation and induces apoptosis in breast-cancer cell lines. International Journal of Cancer. 78(1). 86–94. 40 indexed citations

Toma, Salvatore, L Isnardi, P Raffo, et al.. (1997). Effects of ALL-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: Growth inhibition and apoptosis induction. International Journal of Cancer. 70(5). 619–627. 102 indexed citations

Majewski, Sławomir, et al.. (1996). Interleukin-12 Inhibits Angiogenesis Induced by Human Tumor Cell Lines In Vivo. Journal of Investigative Dermatology. 106(5). 1114–1118. 55 indexed citations

Bollag, Werner. (1996). The retinoid revolution. The FASEB Journal. 10(9). 938–939. 19 indexed citations

Bollag, Werner. (1994). Experimental basis of cancer combination chemotherapy with retinoids, cytokines, 1,25‐dihydroxyvitamin D₃, and analogs. Journal of Cellular Biochemistry. 56(4). 427–435. 29 indexed citations

Bollag, Werner. (1994). Retinoids in oncology: Experimental and clinical aspects. Pure and Applied Chemistry. 66(5). 995–1002. 4 indexed citations

Bollag, Werner, et al.. (1993). Retinoids. Current Opinion in Oncology. 5(6). 1059–1066. 11 indexed citations

10.

Bollag, Werner & Richard Peck. (1991). Modulation of Human Immune Functions in vitro by Temarotene and Its Metabolite. Skin Pharmacology and Physiology. 4(3). 142–149. 2 indexed citations

11.

Peck, Richard & Werner Bollag. (1991). Potentiation of retinoid-induced differentiation of HL-60 and U937 cell lines by cytokines. European Journal of Cancer and Clinical Oncology. 27(1). 53–57. 55 indexed citations

12.

Bollag, Werner, et al.. (1990). The Relevance of the Mouse Papilloma Test as a Predictor of Retinoid Activity in Human Psoriasis. Dermatology. 180(1). 30–35. 3 indexed citations

13.

Bollag, Werner, et al.. (1988). Therapeutic effect of the arotinoid Ro 15-0778 on chemically induced rat mammary carcinoma. European Journal of Cancer and Clinical Oncology. 24(7). 1205–1209. 11 indexed citations

14.

Bollag, Werner, et al.. (1986). Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine. Medical Oncology and Tumor Pharmacotherapy. 3(2). 111–118. 5 indexed citations

15.

Bollag, Werner. (1983). The development of retinoids in experimental and clinical oncology and dermatology. Journal of the American Academy of Dermatology. 9(5). 797–805. 46 indexed citations

16.

Bollag, Werner. (1981). Arotinoids. Cancer Chemotherapy and Pharmacology. 7(1). 27–9. 31 indexed citations

17.

Matter, Alex, et al.. (1980). Ultrastructural analysis of the retinoid-induced reversal of epithelial hyperplasia and metaplasia. Virchows Archiv B Cell Pathology Including Molecular Pathology. 33(1). 199–212. 5 indexed citations

18.

Bollag, Werner. (1974). Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice. European Journal of Cancer (1965). 10(11). 731–737. 164 indexed citations

19.

Bollag, Werner. (1972). Prophylaxis of chemically induced benign and malignant epithelial tumors by vitamin A acid (retinoic acid). European Journal of Cancer (1965). 8(6). 689–693. 245 indexed citations

20.

Bollag, Werner, et al.. (1952). The effect of dl-ethionine on the content of some enzymes in pancreas and liver. Biochimica et Biophysica Acta. 9(2). 193–198. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact